Article summary
The European Medicines Agency (EMA) has published its detailed guide regarding the EudraVigilance (EV) data management activities. The guide provides and overview of the data management and quality assurance activities carried out by the EMA, based on information of suspected adverse reactions and medicinal products reported to and held in EV and the extended EV medicinal product dictionary (XEVMPD). The EMA have stated that organisations submitting individual case safety reports (ICSRs) electronically to EV, have to demonstrate that they have an ICH E2B(R2)2 or E2B(R3)3 compliant system.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial